Nanoparticle-Based Photomedicine Techniques

Nanoparticle-based photomedicine harnesses light-responsive nanoscale carriers to diagnose, monitor and treat disease with high spatial precision. By integrating photosensitisers, photothermal agents and imaging contrast elements within a single platform, these constructs enable external control over drug release, enhanced tumour targeting and real-time feedback on therapeutic efficacy. Key modalities include photodynamic therapy, in which light-activated molecules generate reactive oxygen species to induce cytotoxicity, and photothermal therapy, where photon absorption is converted into localised heat. Advanced designs incorporate photoacoustic imaging for deep-tissue visualisation, multimodal fluorescence tracking for biodistribution studies and endoscopic devices to trigger and monitor release in situ. Innovations in surface chemistry and biocompatible coatings have improved circulation times and reduced off-target effects. The global significance of these approaches lies in their potential to minimise systemic toxicity, overcome multidrug resistance and provide personalised treatment regimens. Emerging applications span oncology, antimicrobial therapies and vascular interventions, pointing to a future in which light-guided nanomedicine delivers safer, more effective interventions across a broad spectrum of clinical contexts.

Research from Nature Portfolio

Recent studies have demonstrated controlled drug delivery through light-permeabilised liposomal bilayers. One pioneering approach embeds porphyrin–lipid conjugates within liposome membranes, enabling near-infrared irradiation to induce transient permeability without bulk heating. This platform affords precise temporal and spatial control of cargo release, enhancing intratumoural accumulation of chemotherapeutics and reducing systemic exposure. In parallel, a dual-channel endoscopic system has been developed to integrate light delivery, quantitative fluorescence imaging and reflectance monitoring. This device enables on-demand release of encapsulated agents, such as doxorubicin, while simultaneously mapping local drug concentration kinetics in living tissue. By combining imaging and actuation in a single probe, this work exemplifies a theranostic paradigm that unites diagnosis, therapy and real-time feedback in one minimally invasive procedure.

Nanoparticle-Based Photomedicine Techniques publication trend

The graph below shows the total number of articles in nanoparticle-based photomedicine techniques across all publications each year (not limited to Nature Index journals).

Technical terms

Photodynamic therapy (PDT): Treatment modality in which a photosensitiser upon light activation produces reactive oxygen species to kill target cells.

Photothermal conversion efficiency: Measure of a material’s ability to convert absorbed light into heat for therapeutic applications.

Photosensitiser: A molecule that absorbs specific wavelengths of light and transfers energy to molecular oxygen or other substrates.

Photoacoustic imaging: Technique combining pulsed light excitation and ultrasound detection to visualise deep-tissue structures with high resolution.

Reactive oxygen species (ROS): Chemically reactive molecules derived from oxygen that can induce oxidative damage to cellular components.

References

1. Multifunctional and Scalable Nanoparticles for Bimodal Image-Guided Phototherapy in Bladder Cancer Treatment. Nano-Micro Letters (2025).
2. Light‐Activatable Liquid Metal Immunostimulants for Cancer Nanotheranostics. Advanced Functional Materials (2023).
3. Far-red light-triggered cargo release from liposomes b ound to a photosensitizer-cellulose nanofiber hydrogel. Carbohydrate Polymers (2024).
4. Porphyrin–phospholipid liposomes permeabilized by near-infrared light. Nature Communications (2014).
5. A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice. Scientific Reports (2017).